Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1953 1
1957 2
1959 2
1961 3
1962 1
1963 1
1965 1
1966 1
1978 2
1979 1
1981 1
1982 1
1983 1
1984 1
1985 1
1986 2
1987 5
1988 1
1989 2
1991 4
1992 2
1993 2
1994 4
1995 3
1996 5
1997 7
1998 4
1999 9
2000 5
2001 2
2002 4
2003 9
2004 6
2005 10
2006 9
2007 19
2008 14
2009 13
2010 11
2011 21
2012 14
2013 12
2014 22
2015 32
2016 35
2017 42
2018 42
2019 50
2020 64
2021 60
2022 53
2023 60
2024 63
2025 48
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

704 results

Results by year

Filters applied: . Clear all
Page 1
Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer.
Loree JM, Wang Y, Syed MA, Sorokin AV, Coker O, Xiu J, Weinberg BA, Vanderwalde AM, Tesfaye A, Raymond VM, Miron B, Tarcic G, Zelichov O, Broaddus RR, Ng PKS, Jeong KJ, Tsang YH, Mills GB, Overman MJ, Grothey A, Marshall JL, Kopetz S. Loree JM, et al. Among authors: tsang yh. Clin Cancer Res. 2021 Aug 15;27(16):4587-4598. doi: 10.1158/1078-0432.CCR-21-0180. Epub 2021 Jun 11. Clin Cancer Res. 2021. PMID: 34117033 Free PMC article.
ESTRO clinical practice guideline: Stereotactic body radiotherapy for spine metastases.
Guckenberger M, Andratschke N, Belka C, Bellut D, Cuccia F, Dahele M, Guninski RS, Josipovic M, Mancosu P, Minniti G, Niyazi M, Ricardi U, Munck Af Rosenschold P, Sahgal A, Tsang Y, Verbakel W, Alongi F. Guckenberger M, et al. Among authors: tsang y. Radiother Oncol. 2024 Jan;190:109966. doi: 10.1016/j.radonc.2023.109966. Epub 2023 Nov 2. Radiother Oncol. 2024. PMID: 37925107 Free article.
Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer.
Brunt AM, Haviland JS, Sydenham M, Agrawal RK, Algurafi H, Alhasso A, Barrett-Lee P, Bliss P, Bloomfield D, Bowen J, Donovan E, Goodman A, Harnett A, Hogg M, Kumar S, Passant H, Quigley M, Sherwin L, Stewart A, Syndikus I, Tremlett J, Tsang Y, Venables K, Wheatley D, Bliss JM, Yarnold JR. Brunt AM, et al. Among authors: tsang y. J Clin Oncol. 2020 Oct 1;38(28):3261-3272. doi: 10.1200/JCO.19.02750. Epub 2020 Jul 14. J Clin Oncol. 2020. PMID: 32663119 Free PMC article. Clinical Trial.
An international Delphi consensus for pelvic stereotactic ablative radiotherapy re-irradiation.
Slevin F, Aitken K, Alongi F, Arcangeli S, Chadwick E, Chang AR, Cheung P, Crane C, Guckenberger M, Jereczek-Fossa BA, Kamran SC, Kinj R, Loi M, Mahadevan A, Massaccesi M, Mendez LC, Muirhead R, Pasquier D, Pontoriero A, Spratt DE, Tsang YM, Zelefsky MJ, Lilley J, Dickinson P, Hawkins MA, Henry AM, Murray LJ. Slevin F, et al. Among authors: tsang ym. Radiother Oncol. 2021 Nov;164:104-114. doi: 10.1016/j.radonc.2021.09.010. Epub 2021 Sep 21. Radiother Oncol. 2021. PMID: 34560186
Efficacy and safety of SBRT for spine metastases: A systematic review and meta-analysis for preparation of an ESTRO practice guideline.
Guninski RS, Cuccia F, Alongi F, Andratschke N, Belka C, Bellut D, Dahele M, Josipovic M, Kroese TE, Mancosu P, Minniti G, Niyazi M, Ricardi U, Munck Af Rosenschold P, Sahgal A, Tsang Y, Verbakel WFAR, Guckenberger M. Guninski RS, et al. Among authors: tsang y. Radiother Oncol. 2024 Jan;190:109969. doi: 10.1016/j.radonc.2023.109969. Epub 2023 Nov 2. Radiother Oncol. 2024. PMID: 37922993 Free article.
Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial.
Coles CE, Haviland JS, Kirby AM, Griffin CL, Sydenham MA, Titley JC, Bhattacharya I, Brunt AM, Chan HYC, Donovan EM, Eaton DJ, Emson M, Hopwood P, Jefford ML, Lightowlers SV, Sawyer EJ, Syndikus I, Tsang YM, Twyman NI, Yarnold JR, Bliss JM; IMPORT Trial Management Group. Coles CE, et al. Among authors: tsang ym. Lancet. 2023 Jun 24;401(10394):2124-2137. doi: 10.1016/S0140-6736(23)00619-0. Epub 2023 Jun 8. Lancet. 2023. PMID: 37302395 Free article. Clinical Trial.
704 results